SMMT Summit Therapeutics PLC ADRs

Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:SUMM.

$7.67  -0.32 (-4.01%)
As of 07/29/2021 15:56:44 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  03/04/2015
Outstanding shares:  97,244,567
Average volume:  148,865
Market cap:   $736,141,372
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    86627T108
ISIN:        US86627T1088
Sedol:      BMTVQS7

---

Valuation   (See tab for details)

---

PE ratio:   -15.94
PB ratio:   10.28
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%